학술논문

Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves
Document Type
Academic Journal
Source
EHJ Case Reports. April, 2022, Vol. 6 Issue 4
Subject
Prosthesis
Comorbidity
Implants, Artificial
Clopidogrel
Type 2 diabetes
Language
English
ISSN
2514-2119
Abstract
Background Patients with severe tricuspid valve stenosis or dysfunction following degeneration of biological valve prosthesis in tricuspid pos ition are complex, have substantial comorbidity, and very high surgical risk. Case summary We report two cases with transcatheter tricuspid valve-in-valve implantation in patients with degenerated tricuspid bioprosthesis with transfemoral and transjugular access with Sapien 3 valve and MyVal, respectively. Discussion In patients with high surgical risk, transcatheter tricuspid valve implantation is a good alternative. Careful consideration of op timal access site, device size, and delivery system is paramount. This case report demonstrates technically feasible and safe transcatheter valve-in-valve implantantion in tricuspid position and highlights the importance of meticulous procedure planning. Keywords Transcatheter valve implantation * Tricuspid bioprosthesis failure * Tricuspid valve stenosis * Valve-in-valve * Case report * Transjugular access ESC Curriculum 4.6 Tricuspid stenosis * 4.5 Tricuspid regurgitation * 4.10 Prosthetic valves * 7.4 Percutaneous cardiovascular post-procedure * 7.5 Cardiac surgery
Introduction Patients with severe tricuspid valve disease (dysfunction) demanding tricuspid valve intervention are, although they may be young, often complex, have substantial comorbidity and often multivalve involvement. (1,2) Both mechanical [...]